Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Hybridon enters research collaborations for antisense therapies

Sep. 13, 1996

Sugen and ArQule drug discovery collaboration

Sep. 13, 1996

Broad patent coverage for Genelabs' drug discovery tool

Sep. 13, 1996

Cellegy issued patent covering novel drug delivery system

Sep. 6, 1996

ImmunoTherapeutics obtains option for drug delivery technology

Sep. 6, 1996

Molecular Simulations and Procept enter research collaboration

Sep. 6, 1996

Renewed collaboration for Ribozyme and Pharmacia Biotech

Sep. 6, 1996

Ontogen and Boehringer Ingelheim sign research agreement

Sep. 6, 1996

Celox Laboratories' ViaStem covered under patent

Aug. 30, 1996

Medtronic acquires catheter product line

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.